Inflammatory Bowel Disease Market Report

China Inflammatory Bowel Disease Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：165
  • REPORT CODE：GMM1758930
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Inflammatory Bowel Disease industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • Shire

    • Celltrion

    • Pfizer

    • Ferring Pharmaceuticals

    • Akebia Therapeutics

    • UCB

    • Salix Pharmaceuticals

    • Abbvie

    • Merck & Company

    • Genentech

    • Boehringer Ingelheim

    • Mitsubishi Tanabe

    • Abbott Laboratories

    • Novo Nordisk

    • Novartis

    • Biogen Idec

    • ChemoCentryx

    By Type:

    • 5-ASA

    • Other

    • Immunomodulators

    • Antibiotics

    By Application:

    • Hospital

    • Clinic

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Inflammatory Bowel Disease Market Overview 2018-2029

    • 1.1 China Inflammatory Bowel Disease Industry Development Overview

    • 1.2 China Inflammatory Bowel Disease Industry Development History

    • 1.3 China Inflammatory Bowel Disease Industry Market Size (2018-2029)

    • 1.4 China Inflammatory Bowel Disease Market Analysis by Type from Production Side

      • 1.4.1 China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of 5-ASA (2018-2029)

      • 1.4.2 China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.3 China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of Immunomodulators (2018-2029)

      • 1.4.4 China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of Antibiotics (2018-2029)

    • 1.5 China Inflammatory Bowel Disease Market Analysis by Application from Consumption End

      • 1.5.1 China Inflammatory Bowel Disease Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Inflammatory Bowel Disease Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.3 China Inflammatory Bowel Disease Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China Inflammatory Bowel Disease Market Analysis by Region

      • 1.6.1 North China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    Chapter 2 China Inflammatory Bowel Disease Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Inflammatory Bowel Disease Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Inflammatory Bowel Disease Market Status and Competition Analysis in 2023

      • 2.2.3 China Inflammatory Bowel Disease Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Inflammatory Bowel Disease Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Inflammatory Bowel Disease Industry Development

    Chapter 3 Inflammatory Bowel DiseaseIndustry Chain Analysis

    • 3.1 Inflammatory Bowel Disease Industry Chain

    • 3.2 Inflammatory Bowel Disease Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Inflammatory Bowel Disease Market

    • 3.3 Inflammatory Bowel Disease Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Inflammatory Bowel Disease Market

    Chapter 4 China Inflammatory Bowel Disease Market, by Type

    • 4.1 China Inflammatory Bowel Disease Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Inflammatory Bowel Disease Total Production Volume and Growth Rate from Production Side

    • 4.5 China Inflammatory Bowel Disease Production Volume and Growth Rate, by Type

      • 4.5.1 China Inflammatory Bowel Disease Production Volume and Growth Rate of 5-ASA

      • 4.5.2 China Inflammatory Bowel Disease Production Volume and Growth Rate of Other

      • 4.5.3 China Inflammatory Bowel Disease Production Volume and Growth Rate of Immunomodulators

      • 4.5.4 China Inflammatory Bowel Disease Production Volume and Growth Rate of Antibiotics

    Chapter 5 China Inflammatory Bowel Disease Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Inflammatory Bowel Disease Total Market Size and Growth Rate from Consumption End

    • 5.5 China Inflammatory Bowel Disease Market Size and Growth Rate, by Application

      • 5.5.1 China Inflammatory Bowel Disease Market Size and Growth Rate of Hospital

      • 5.5.2 China Inflammatory Bowel Disease Market Size and Growth Rate of Clinic

      • 5.5.3 China Inflammatory Bowel Disease Market Size and Growth Rate of Other

    Chapter 6 China Inflammatory Bowel Disease Market, by Region

    • 6.1 China Inflammatory Bowel Disease Production Volume and Production Value, by Region

    • 6.2 China Inflammatory Bowel Disease Sales Volume and Sales Value, by Region

    Chapter 7 North China Inflammatory Bowel Disease Market Analysis

    • 7.1 North China Inflammatory Bowel Disease Market, by Type

    • 7.2 North China Inflammatory Bowel Disease Market, by Application

    Chapter 8 Central China Inflammatory Bowel Disease Market Analysis

    • 8.1 Central China Inflammatory Bowel Disease Market, by Type

    • 8.2 Central China Inflammatory Bowel Disease Market, by Application

    Chapter 9 South China Inflammatory Bowel Disease Market Analysis

    • 9.1 South China Inflammatory Bowel Disease Market, by Type

    • 9.2 South China Inflammatory Bowel Disease Market, by Application

    Chapter 10 East China Inflammatory Bowel Disease Market Analysis

    • 10.1 East China Inflammatory Bowel Disease Market, by Type

    • 10.2 East China Inflammatory Bowel Disease Market, by Application

    Chapter 11 Northeast China Inflammatory Bowel Disease Market Analysis

    • 11.1 Northeast China Inflammatory Bowel Disease Market, by Type

    • 11.2 Northeast China Inflammatory Bowel Disease Market, by Application

    Chapter 12 Southwest China Inflammatory Bowel Disease Market Analysis

    • 12.1 Southwest China Inflammatory Bowel Disease Market, by Type

    • 12.2 Southwest China Inflammatory Bowel Disease Market, by Application

    Chapter 13 Northwest China Inflammatory Bowel Disease Market Analysis

    • 13.1 Northwest China Inflammatory Bowel Disease Market, by Type

    • 13.2 Northwest China Inflammatory Bowel Disease Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Inflammatory Bowel Disease Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Shire

        • 14.2.1 Shire Company Profile

        • 14.2.2 Shire Inflammatory Bowel Disease Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Celltrion

        • 14.3.1 Celltrion Company Profile

        • 14.3.2 Celltrion Inflammatory Bowel Disease Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pfizer

        • 14.4.1 Pfizer Company Profile

        • 14.4.2 Pfizer Inflammatory Bowel Disease Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Ferring Pharmaceuticals

        • 14.5.1 Ferring Pharmaceuticals Company Profile

        • 14.5.2 Ferring Pharmaceuticals Inflammatory Bowel Disease Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Akebia Therapeutics

        • 14.6.1 Akebia Therapeutics Company Profile

        • 14.6.2 Akebia Therapeutics Inflammatory Bowel Disease Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 UCB

        • 14.7.1 UCB Company Profile

        • 14.7.2 UCB Inflammatory Bowel Disease Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Salix Pharmaceuticals

        • 14.8.1 Salix Pharmaceuticals Company Profile

        • 14.8.2 Salix Pharmaceuticals Inflammatory Bowel Disease Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbvie

        • 14.9.1 Abbvie Company Profile

        • 14.9.2 Abbvie Inflammatory Bowel Disease Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Merck & Company

        • 14.10.1 Merck & Company Company Profile

        • 14.10.2 Merck & Company Inflammatory Bowel Disease Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Genentech

        • 14.11.1 Genentech Company Profile

        • 14.11.2 Genentech Inflammatory Bowel Disease Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Boehringer Ingelheim

        • 14.12.1 Boehringer Ingelheim Company Profile

        • 14.12.2 Boehringer Ingelheim Inflammatory Bowel Disease Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Mitsubishi Tanabe

        • 14.13.1 Mitsubishi Tanabe Company Profile

        • 14.13.2 Mitsubishi Tanabe Inflammatory Bowel Disease Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Abbott Laboratories

        • 14.14.1 Abbott Laboratories Company Profile

        • 14.14.2 Abbott Laboratories Inflammatory Bowel Disease Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Novo Nordisk

        • 14.15.1 Novo Nordisk Company Profile

        • 14.15.2 Novo Nordisk Inflammatory Bowel Disease Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Novartis

        • 14.16.1 Novartis Company Profile

        • 14.16.2 Novartis Inflammatory Bowel Disease Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Biogen Idec

        • 14.17.1 Biogen Idec Company Profile

        • 14.17.2 Biogen Idec Inflammatory Bowel Disease Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 ChemoCentryx

        • 14.18.1 ChemoCentryx Company Profile

        • 14.18.2 ChemoCentryx Inflammatory Bowel Disease Market Performance

        • 14.18.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Inflammatory Bowel Disease Industry Research Conclusions

    • 15.2 Inflammatory Bowel Disease Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Inflammatory Bowel Disease Industry Market Size (2018-2029)

    • Figure China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of 5-ASA (2018-2029)

    • Figure China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of Immunomodulators (2018-2029)

    • Figure China Inflammatory Bowel Disease Production Volume, Production Value and Growth Rate of Antibiotics (2018-2029)

    • Figure China Inflammatory Bowel Disease Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Inflammatory Bowel Disease Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Inflammatory Bowel Disease Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure Central China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure South China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure East China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Inflammatory Bowel Disease Market Size and Growth Rate from 2018-2029

    • Figure Inflammatory Bowel Disease Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Inflammatory Bowel Disease Market Share by Type in 2018

    • Figure China Inflammatory Bowel Disease Market Share by Type in 2023

    • Figure China Inflammatory Bowel Disease Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Inflammatory Bowel Disease Production Volume and Growth Rate of 5-ASA (2018-2023)

    • Figure China Inflammatory Bowel Disease Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Inflammatory Bowel Disease Production Volume and Growth Rate of Immunomodulators (2018-2023)

    • Figure China Inflammatory Bowel Disease Production Volume and Growth Rate of Antibiotics (2018-2023)

    • Figure China Inflammatory Bowel Disease Market Share by Application in 2018

    • Figure China Inflammatory Bowel Disease Market Share by Application in 2023

    • Figure China Inflammatory Bowel Disease Total Market Size and Growth Rate from Consumption End

    • Figure China Inflammatory Bowel Disease Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Inflammatory Bowel Disease Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Inflammatory Bowel Disease Market Size and Growth Rate of Other (2018-2023)

    • Table China Inflammatory Bowel Disease Production Volume by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Production Volume Share by Region (2018-2023)

    • Figure China Inflammatory Bowel Disease Production Volume Share by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Production Value by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Production Value Share by Region (2018-2023)

    • Figure China Inflammatory Bowel Disease Production Value Share by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Sales Volume by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Sales Volume Share by Region (2018-2023)

    • Figure China Inflammatory Bowel Disease Sales Volume Share by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Sales Value by Region (2018-2023)

    • Table China Inflammatory Bowel Disease Sales Value Share by Region (2018-2023)

    • Figure China Inflammatory Bowel Disease Sales Value Share by Region (2018-2023)

    • Table North China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table North China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure North China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table North China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table North China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure North China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table Central China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table Central China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure Central China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table Central China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table Central China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure Central China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table South China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table South China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure South China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table South China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table South China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure South China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table East China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table East China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure East China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table East China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table East China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure East China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table Northeast China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table Northeast China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure Northeast China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table Northeast China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table Northeast China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table Southwest China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table Southwest China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure Southwest China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table Southwest China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table Southwest China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table Northwest China Inflammatory Bowel Disease Production Volume by Type (2018-2023)

    • Table Northwest China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Figure Northwest China Inflammatory Bowel Disease Production Volume Share by Type (2018-2023)

    • Table Northwest China Inflammatory Bowel Disease Sales Volume by Application (2018-2023)

    • Table Northwest China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Inflammatory Bowel Disease Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Shire Company Profile

    • Table Shire Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Celltrion Company Profile

    • Table Celltrion Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Ferring Pharmaceuticals Company Profile

    • Table Ferring Pharmaceuticals Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Akebia Therapeutics Company Profile

    • Table Akebia Therapeutics Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table UCB Company Profile

    • Table UCB Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Salix Pharmaceuticals Company Profile

    • Table Salix Pharmaceuticals Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Abbvie Company Profile

    • Table Abbvie Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Merck & Company Company Profile

    • Table Merck & Company Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Mitsubishi Tanabe Company Profile

    • Table Mitsubishi Tanabe Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec Company Profile

    • Table Biogen Idec Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)

    • Table ChemoCentryx Company Profile

    • Table ChemoCentryx Inflammatory Bowel Disease Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US